117 related articles for article (PubMed ID: 21989477)
1. NMDA receptor gene variations as modifiers in Huntington disease: a replication study.
Saft C; Epplen JT; Wieczorek S; Landwehrmeyer GB; Roos RA; de Yebenes JG; Dose M; Tabrizi SJ; Craufurd D; ; Arning L
PLoS Curr; 2011 Oct; 3():RRN1247. PubMed ID: 21989477
[TBL] [Abstract][Full Text] [Related]
2. NR2A and NR2B receptor gene variations modify age at onset in Huntington disease in a sex-specific manner.
Arning L; Saft C; Wieczorek S; Andrich J; Kraus PH; Epplen JT
Hum Genet; 2007 Sep; 122(2):175-82. PubMed ID: 17569088
[TBL] [Abstract][Full Text] [Related]
3. NR2A and NR2B receptor gene variations modify age at onset in Huntington disease.
Arning L; Kraus PH; Valentin S; Saft C; Andrich J; Epplen JT
Neurogenetics; 2005 Feb; 6(1):25-8. PubMed ID: 15742215
[TBL] [Abstract][Full Text] [Related]
4. Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset.
Ramos EM; Latourelle JC; Gillis T; Mysore JS; Squitieri F; Di Pardo A; Di Donato S; Gellera C; Hayden MR; Morrison PJ; Nance M; Ross CA; Margolis RL; Gomez-Tortosa E; Ayuso C; Suchowersky O; Trent RJ; McCusker E; Novelletto A; Frontali M; Jones R; Ashizawa T; Frank S; Saint-Hilaire MH; Hersch SM; Rosas HD; Lucente D; Harrison MB; Zanko A; Abramson RK; Marder K; Gusella JF; Lee JM; Alonso I; Sequeiros J; Myers RH; Macdonald ME
Neurogenetics; 2013 Nov; 14(3-4):173-9. PubMed ID: 23644918
[TBL] [Abstract][Full Text] [Related]
5. Exploring Genetic Factors Involved in Huntington Disease Age of Onset: E2F2 as a New Potential Modifier Gene.
Valcárcel-Ocete L; Alkorta-Aranburu G; Iriondo M; Fullaondo A; García-Barcina M; Fernández-García JM; Lezcano-García E; Losada-Domingo JM; Ruiz-Ojeda J; Álvarez de Arcaya A; Pérez-Ramos JM; Roos RA; Nielsen JE; Saft C; ; Zubiaga AM; Aguirre A
PLoS One; 2015; 10(7):e0131573. PubMed ID: 26148071
[TBL] [Abstract][Full Text] [Related]
6. CNR1 variation is associated with the age at onset in Huntington disease.
Kloster E; Saft C; Epplen JT; Arning L
Eur J Med Genet; 2013 Aug; 56(8):416-9. PubMed ID: 23747361
[TBL] [Abstract][Full Text] [Related]
7. PGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease.
Taherzadeh-Fard E; Saft C; Akkad DA; Wieczorek S; Haghikia A; Chan A; Epplen JT; Arning L
Mol Neurodegener; 2011 May; 6(1):32. PubMed ID: 21595933
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16.
Djoussé L; Knowlton B; Hayden MR; Almqvist EW; Brinkman RR; Ross CA; Margolis RL; Rosenblatt A; Durr A; Dode C; Morrison PJ; Novelletto A; Frontali M; Trent RJ; McCusker E; Gómez-Tortosa E; Mayo Cabrero D; Jones R; Zanko A; Nance M; Abramson RK; Suchowersky O; Paulsen JS; Harrison MB; Yang Q; Cupples LA; Mysore J; Gusella JF; MacDonald ME; Myers RH
Neurogenetics; 2004 Jun; 5(2):109-14. PubMed ID: 15029481
[TBL] [Abstract][Full Text] [Related]
9. Population stratification may bias analysis of PGC-1α as a modifier of age at Huntington disease motor onset.
Ramos EM; Latourelle JC; Lee JH; Gillis T; Mysore JS; Squitieri F; Di Pardo A; Di Donato S; Hayden MR; Morrison PJ; Nance M; Ross CA; Margolis RL; Gomez-Tortosa E; Ayuso C; Suchowersky O; Trent RJ; McCusker E; Novelletto A; Frontali M; Jones R; Ashizawa T; Frank S; Saint-Hilaire MH; Hersch SM; Rosas HD; Lucente D; Harrison MB; Zanko A; Marder K; Gusella JF; Lee JM; Alonso I; Sequeiros J; Myers RH; Macdonald ME
Hum Genet; 2012 Dec; 131(12):1833-40. PubMed ID: 22825315
[TBL] [Abstract][Full Text] [Related]
10. ASK1 and MAP2K6 as modifiers of age at onset in Huntington's disease.
Arning L; Monté D; Hansen W; Wieczorek S; Jagiello P; Akkad DA; Andrich J; Kraus PH; Saft C; Epplen JT
J Mol Med (Berl); 2008 Apr; 86(4):485-90. PubMed ID: 18327563
[TBL] [Abstract][Full Text] [Related]
11. Replication of twelve association studies for Huntington's disease residual age of onset in large Venezuelan kindreds.
Andresen JM; Gayán J; Cherny SS; Brocklebank D; Alkorta-Aranburu G; Addis EA; ; Cardon LR; Housman DE; Wexler NS
J Med Genet; 2007 Jan; 44(1):44-50. PubMed ID: 17018562
[TBL] [Abstract][Full Text] [Related]
12. Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease.
Djoussé L; Knowlton B; Hayden M; Almqvist EW; Brinkman R; Ross C; Margolis R; Rosenblatt A; Durr A; Dode C; Morrison PJ; Novelletto A; Frontali M; Trent RJ; McCusker E; Gómez-Tortosa E; Mayo D; Jones R; Zanko A; Nance M; Abramson R; Suchowersky O; Paulsen J; Harrison M; Yang Q; Cupples LA; Gusella JF; MacDonald ME; Myers RH
Am J Med Genet A; 2003 Jun; 119A(3):279-82. PubMed ID: 12784292
[TBL] [Abstract][Full Text] [Related]
13. Assessment of NMDA receptor genes (GRIN2A, GRIN2B and GRIN2C) as candidate genes in the development of degenerative lumbar scoliosis.
Kim KT; Kim J; Han YJ; Kim JH; Lee JS; Chung JH
Exp Ther Med; 2013 Mar; 5(3):977-981. PubMed ID: 23408766
[TBL] [Abstract][Full Text] [Related]
14. Study of Early Onset Schizophrenia: Associations of
Poltavskaya EG; Fedorenko OY; Kornetova EG; Loonen AJM; Kornetov AN; Bokhan NA; Ivanova SA
Life (Basel); 2021 Sep; 11(10):. PubMed ID: 34685369
[TBL] [Abstract][Full Text] [Related]
15. Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length.
Kehoe P; Krawczak M; Harper PS; Owen MJ; Jones AL
J Med Genet; 1999 Feb; 36(2):108-11. PubMed ID: 10051007
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms of GRIN2A and GRIN2B modify the neurobehavioral effects of low-level lead exposure in children.
Rooney JPK; Woods NF; Martin MD; Woods JS
Environ Res; 2018 Aug; 165():1-10. PubMed ID: 29655037
[TBL] [Abstract][Full Text] [Related]
17. Modulation of age at onset of Huntington disease patients by variations in TP53 and human caspase activated DNase (hCAD) genes.
Chattopadhyay B; Baksi K; Mukhopadhyay S; Bhattacharyya NP
Neurosci Lett; 2005 Feb; 374(2):81-6. PubMed ID: 15644269
[TBL] [Abstract][Full Text] [Related]
18. Modulation at age of onset in tunisian huntington disease patients: implication of new modifier genes.
Hmida-Ben Brahim D; Chourabi M; Ben Amor S; Harrabi I; Trabelsi S; Haddaji-Mastouri M; Gribaa M; Sassi S; Gahbiche FE; Lamouchi T; Mougou-Zereli S; Ben Ammou S; Saad A
Genet Res Int; 2014; 2014():210418. PubMed ID: 25254119
[TBL] [Abstract][Full Text] [Related]
19. Age at onset of Huntington disease is not modulated by the R72P variation in TP53 and the R196K variation in the gene coding for the human caspase activated DNase (hCAD).
Arning L; Kraus PH; Saft C; Andrich J; Epplen JT
BMC Med Genet; 2005 Oct; 6():35. PubMed ID: 16202123
[TBL] [Abstract][Full Text] [Related]
20. No association between polymorphisms in the BDNF gene and age at onset in Huntington disease.
Mai M; Akkad AD; Wieczorek S; Saft C; Andrich J; Kraus PH; Epplen JT; Arning L
BMC Med Genet; 2006 Nov; 7():79. PubMed ID: 17096834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
